Visualitza per autor "Boni, valentina"
Ara mostrant els elements 1-5 d 5
-
Antitumor activity of lurbinectedin in combination with oral capecitabine in patients with metastatic breast cancer
Awada, Ahmad; Moreno, Victor; Aftimos, Philippe; Kahatt, Carmen; Luepke Estefan, Xarles Erik; Boni, Valentina; Tabernero, Josep (Elsevier, 2022-12) -
Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II Study
Braña Garcia, Irene; Longhi, Alessandra; Awada, Ahmad; Subbiah, Vivek; Boni, Valentina; Delord, Jean-Pierre (American Association for Cancer Research, 2022-07-01) -
Lurbinectedin, a selective inhibitor of oncogenic transcription, in patients with pretreated germline BRCA1/2 metastatic breast cancer: results from a phase II basket study
Pistilli, Barbara; Braña Garcia, Irene; Shapiro, G. I.; Trigo, José Manuel; Boni, Valentina; Moreno, Victor (Elsevier, 2022-10) -
Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer
Jhaveri, Komal; Loi, Sherene; Bardia, Aditya; Bellet Ezquerra, Meritxell; Turner, Nicholas; Boni, valentina (American Association for Cancer Research, 2024-02-15) -
Pooled Safety Analysis of Single-Agent Lurbinectedin in Patients With Advanced Solid Tumours
leary, alexandra; Trigo, José Manuel; DELORD, Jean-Pierre; Boni, valentina; OAKNIN, ANA; Brana, Irene; Moreno, Victor (Elsevier, 2023-10)